Ureaplasmosis in women is an infectious inflammatory disease of the urino-genital organs caused by pathological activity of the ureaplasma. In 70-80% of cases, the disease occurs in the form of asymptomatic carriage. It can be manifested by nonspecific dysuric symptoms, an increase in the number of transparent vaginal secretions, pulling pains in the lower abdomen and a violation of reproductive function. For the diagnosis use bacterial culture, PCR, ELISA, UIF. Etiotropic treatment involves the appointment of antibacterial drugs macrolides, tetracyclines and fluoroquinolones.
For the first time ureaplasma was isolated from the patient with non-gonococcal urethritis in 1954. To date, the pathogen is considered a conditionally pathogenic microorganism, exhibiting pathological activity only in the presence of certain factors. Carriers of bacteria are 40-50% of sexually active healthy women. The microorganism is detected on the genitals of every third newborn girl and 5-22% of schoolgirls who do not live sexually. Although ureaplasma results were the only microorganisms detected in some patients with infertility and chronic diseases of the urogenital sphere, ureaplasmosis was not included as an independent disease in the current International Classification of Diseases.
In 70-80% of cases, there are no clinical manifestations indicating infection of the body with ureaplasms. The disease has no specific symptoms and during periods of exacerbation manifests itself as signs characteristic of inflammatory processes in the genitourinary system. A woman can complain of discomfort, rezi, burning, soreness when urinating. The volume of transparent vaginal discharge increases slightly.
It is important to note that the indications for prescribing etiotropic anti-ureaplasma treatment are limited. As a rule, antibiotics are used when ureaplasma is detected in patients with chronic inflammatory processes resistant to treatment and reproductive disturbances in the absence of other pathogens of STI. Also, the antibacterial course is recommended to carers of ureaplasma, who plan a pregnancy.